Concepedia

Frédéric Bornancin

FB

56

Publications

4K

Citations

30

H-Index

1989

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis (Austria)

Novartis Institutes for BioMedical Research

The Honourable Society of Lincoln's Inn

Institut de Pharmacologie Moléculaire et Cellulaire

Frédéric Bornancin is an author at Novartis (Switzerland) specializing in medicine, cell signaling, and cell biology.

ORCID

Top concepts

Publications per year

1989–2023

56

Publications

56

Phosphorylation of the Immunomodulatory Drug FTY720 by Sphingosine Kinases

Andreas Billich, Frédéric Bornancin, Piroska Dévay et al. · Journal of Biological Chemistry · 2003 · 431 citations · Full text

Imaging Protein Kinase Cα Activation in Cells

Tony Ng, Anthony Squire, Gurdip Hansra et al. · Science · 1999 · 287 citations

Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720

Barbara Zemann, Bernd Kinzel, Mathias Müller et al. · Blood · 2005 · 262 citations · Full text

Phosphorylation of Protein Kinase C-α on Serine 657 Controls the Accumulation of Active Enzyme and Contributes to Its Phosphatase-resistant State

Frédéric Bornancin, Peter J. Parker · Journal of Biological Chemistry · 1997 · 191 citations · Full text

Phosphorylation of threonine 638 critically controls the dephosphorylation and inactivation of protein kinase Cα

Frédéric Bornancin, Peter J. Parker · Current Biology · 1996 · 176 citations · Full text

, , +11

Rows per page

1–5 of 56